News release

Date: 3rd July 2013

Advanced research instrumentation pioneer Oxford Optronix launches next-generation tissue oxygenation and blood flow monitoring systems

OxyLite™ Pro and OxyFlo™ Pro systems combine to deliver an advanced and unique tissue vitality monitoring platform




Abingdon, UK, July 3rd 2013Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces the formal launch of its next-generation OxyLite™ Pro and OxyFlo™ Pro systems for tissue oxygenation and blood flow monitoring – delivering the most advanced tissue vitality monitoring platform on the market today.

This latest release marks the third generation of the company’s OxyLite™ and OxyFlo™ brand systems, first launched in 1991. The OxyLite and OxyFlo systems are unique modular instruments that utilise fibre-optic micro-sensors to provide real-time measurements of local tissue oxygenation (ptiO2), tissue blood perfusion (blood flow) and tissue temperature. These instruments, which are designed to be used either individually or ‘in-tandem’ for simultaneous measurements of tissue oxygenation, blood flow and temperature, are widely used across the globe in areas of biomedical research concerned with hypoxia and ischaemia.

With oxygen sensors based on state-of-the-art optical fluorescence technology – pioneered at Oxford Optronix – OxyLite™ Pro is a two- or four-channel oxygen and temperature monitoring instrument that provides continuous, quantitative and high-sensitivity monitoring of oxygen availability to cells and tissue. This touch-screen based system is remarkably easy to use and is specifically targeted at oxygen measurements in the physiological range, as well as under conditions of hypoxia, offering application in research areas including tumour oxygen monitoring/angiogenesis; cerebral oxygen monitoring in models of stroke and brain injury; vital organ and muscle tissue monitoring; flap monitoring; ophthalmology; wound healing, fMRI-validation techniques; and in-vitro dissolved oxygen monitoring in cell culture and bioreactors.

OxyFlo™ Pro is the company’s third-generation, two- or four-channel laser-Doppler tissue blood flow monitoring instrument. Oxford Optronix is a pioneer in the development of laser-Doppler based blood flow monitoring (LDF) technology and its latest touch-screen, high-performance system sets a new standard in sensitivity and ease of use. An ideal system for measuring changing tissue blood flow in acute experimental models, OxyFlo™ Pro offers applications in peripheral vascular disorders; cerebral perfusion monitoring in models of stroke and brain injury; tumour perfusion monitoring/angiogenesis; blood flow in free flaps and pedicle flaps; wound healing; and gastroenterology.

Commenting on the combined system, Dr Hai-Ling Margaret Cheng of University of Toronto, Hospital for Sick Children in Canada said: “In our studies on the response to gas inhalation in abdominal organs, OxyLite and OxyFlo allowed us to monitor tissue pO2 and perfusion response simultaneously in the liver and kidney. No other minimally invasive system could capture dynamic changes with such fine temporal resolution, and no other system could provide concurrent pO2 and perfusion measurement in multiple tissue regions. Oxford Optronix enabled us to understand the physiological phenomena underlying our magnetic resonance imaging measurements. It is truly a powerful, must-have technology.”

Andy Obeid PhD, CEO of Oxford Optronix added: “The release of our new OxyLite™ Pro and OxyFlo™ Pro systems is the culmination of 5 years of continued product development in this area for us.” He added: “We work closely with our customers to develop targeted solutions that offer unmatched sensitivity, stability and accuracy coupled with total ease-of-use. The introduction of our third-generation platform, enables us to continue providing the ‘gold-standard’ in tissue vitality monitoring that our customers have come to expect.”

For more information regarding Oxford Optronix’s OxyLite™ Pro and OxyFlo™ Pro systems and for links to customer testimonials, please visit http://bit.ly/11xDxsA and http://bit.ly/12uFlS0

--- ends ---

Note to editors:
If you would be interested in scheduling a briefing with Oxford Optronix, please contact Nicky Denovan at nicky[at]evokedset[dot]com.

Press contacts:
Nicky Denovan
EvokedSet PR
nicky [at] evokedset [dot] com
Phone: +44 (0)7747 017654

About Oxford Optronix: (http://www.oxford-optronix.com)
Oxford Optronix is a global pioneer in the design, development and manufacture of sophisticated instrumentation for clinical medicine and life science research.
Founded and managed by academic scientists and with a focus on continuous research and development, Oxford Optronix is committed to making a positive contribution to both patient care and life science research through the design and development of innovative medical devices and scientific instruments for research professionals that set the gold-standard for quality.
Oxford Optronix’s product range includes opto-electronic bio-sensing devices for physiological and tissue vitality monitoring, intelligent imaging systems for automated cell colony counting and contamination-free hypoxia workstations for analysing cell metabolism and function.
With a track record of over 20 years’ success, Oxford Optronix’s team of highly experienced scientists, engineers and technicians design, develop and manufacture its entire product portfolio in-house, ensuring the very highest standards in quality and unparalleled customer support.



Close This Window